Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

October 31, 2023

Welcome to Dominic!

Dominic Mailänder received his Bachelor’s degree in Biology from ETH Zürich in 2022. He is currently enrolled in the Molecular Health Sciences Master’s...

October 6, 2023

Welcome to Marwa!

Marwa Peters Al-Bayati received her MSc in Biology from ETH Zurich in February 2023. Marwa joined the Corn Lab as a PhD student in March 2023.  Her research interests...

September 8, 2023

THE EXPLAINER VIDEO FEATURING OUR HBD PROMOTER RESEARCH IS NOW LIVE!

Check out our new animated video highlighting Mandy’s research on HBD promoter engineering!

 

To learn more, please refer to this article on Elife...

News Archive

Tweets